Reducing antibiotic use in influenza: challenges and rewards

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Molecular evolution of Mycobacterium tuberculosis
Benchmarking inappropriate empirical antibiotic treatment
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room  B.A. Cunha  Clinical Microbiology and Infection 
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Evolution of extended-spectrum β-lactamases by mutation
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Gastroenteritis outbreak caused by norovirus associated with the children's club of a hotel located in Majorca, Spain  A. Doménech-Sánchez  Clinical Microbiology.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Structure of grepafloxacin relative to activity and safety profile
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
Training for the infectious diseases speciality in Norway
Community-acquired pneumonia: the evolving challenge
Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever?  S. Edouard, A. Michel-Lepage, D. Raoult 
Laboratory diagnosis and biosafety issues of biological warfare agents
Bacterial resistance—the clinical challenge
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
J. S. Oxford, S. Bossuyt, S. Balasingam, A. Mann, P. Novelli, R
S. Kurath, G. Halwachs-Baumann, W. Müller, B. Resch 
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Acute schistosomiasis, a diagnostic and therapeutic challenge
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
A.W. Karchmer  Clinical Microbiology and Infection 
Benchmarking inappropriate empirical antibiotic treatment
P.M. Hawkey  Clinical Microbiology and Infection 
Current experience in treating invasive zygomycosis with posaconazole
Clinical infection services—the Leiden experience
Influenza A(H1N1)2009 in the French Pacific territories: assessment of the epidemic wave during the austral winter  Epidemiological Task Group for Overseas.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Reducing antibiotic use in influenza: challenges and rewards D. Low  Clinical Microbiology and Infection  Volume 14, Issue 4, Pages 298-306 (April 2008) DOI: 10.1111/j.1469-0691.2007.01910.x Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Reduction in (a) illness duration and (b) symptom severity with earlier initiation of oseltamivir treatment (75 mg twice-daily) when compared with initiation at 48 h after symptom onset. Reproduced with permission from Aoki et al. [69]. Clinical Microbiology and Infection 2008 14, 298-306DOI: (10.1111/j.1469-0691.2007.01910.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.